Cheng et al. report that analysing structural brain changes across four large datasets, using advanced segmentation, reveals robust associations of Alzheimer’s disease CSF biomarkers (amyloid, tau) with brain volumes, morphometric connectomes and sex differences. The gene discussed is MAPT; the disease is Alzheimer disease.